The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Resarch Into IgG4-Related Diseases Expands Knowledge Base, Leads to Effective Treatments

Resarch Into IgG4-Related Diseases Expands Knowledge Base, Leads to Effective Treatments

August 11, 2016 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF
The Japanese have described IgG4-related disease as a “crow flying in the night.”

The Japanese have described IgG4-related disease as a “crow flying in the night.”
LiuSol/shutterstock.com

CHICAGO—Researchers have come to know a great deal about IgG4-related disease in a short amount of time, leading to effective treatments with the prospect for more, an expert said at the 2016 State-of-the-Art Clinical Symposium.

You Might Also Like
  • Gene Signatures in IgG4-Related Disease
  • Diagnosing, Treating IgG4-Related Disease
  • International Consensus Statement on the Management & Treatment of IgG4-Related Disease
Explore This Issue
August 2016
Also By This Author
  • New Treatment Guidelines to Be Presented at the 2016 ACR/ARHP Annual Meeting

“One of the most exciting things for me is how quickly we’ve been able to move in understanding this disease,” said John Stone, MD, MPH, professor of medicine at Harvard Medical School, Boston. He recalled a patient from several years before with swollen glands. At the time, Dr. Stone had no idea what she had.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

But today, there is a fairly well-developed pathogenic picture of what is happening in the disease, said Dr. Stone, who gained clues into what is now known to be a multi-organ disorder by reviewing isolated case studies in the literature dating as far back as 1899.1

Distinctive Features

One Japanese study, from 2001 in the New England Journal of Medicine, described the way pancreatitis in patients with elevated IgG4 serum levels was different from pancreatitis associated with other hepatobiliary diseases: enlarged, swollen and sausage shaped. These IgG4 levels were affecting many organs, but it wasn’t recognized as doing so. Undetected for what it was, the Japanese described it as a “crow flying in the night.”2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Over the last dozen years, this crow has flown into full light, and we recognize that this disease really can involve every single organ in the body,” Dr. Stone said.

The three hallmarks of the disease that are seen on pathology are a swirling, pink fibrosis or “storiform fibrosis”; a preponderance of plasma cells in that infiltrate staining positive for IgG4; and obliterative phlebitis or lymphoplasmacytic infiltrate moving right through veins and other structures.

This pathology is the same regardless of the organ, whether it’s the kidneys, lungs or even the meninges.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Mass lesions and atopic features—including asthma, allergic rhinitis and nasal polyps—are commonly seen in the disease. One of the more distinctive features, seen in about 12% of patients, is a kind of paravertebral mass that isn’t seen in any other kind of disorder.

Treatment

B cell depletion with rituximab has been found to bring about dramatic improvement in physical symptoms, such as gland size, and in serum IgG4 levels, by depleting the supply of CD20-positive B cells, important players in the disease that are responsible for producing IgG4-producing plasmablasts.3 He discussed rituximab’s effects in one patient, for example, who had a sudden drop in B cells and plasmablasts after treatment, after which the B cell level rebounded, but the plasmablast level remained low, keeping the patient in remission.

Pages: 1 2 | Single Page

Filed Under: Conditions Tagged With: 2016 State-of-the-Art Clinical Symposium, Diagnosis, IgG4 related disease, Research, Rheumatic Disease, rheumatologist, rheumatology, Treatment, updateIssue: August 2016

You Might Also Like:
  • Gene Signatures in IgG4-Related Disease
  • Diagnosing, Treating IgG4-Related Disease
  • International Consensus Statement on the Management & Treatment of IgG4-Related Disease
  • Draft Classification Criteria for IgG4-Related Disease Introduced

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.